Abstract
The regulation of extracellular levels of serotonin (5-HT) and dopamine in response to cocaine by 5-HT 1A receptors was examined using in vivo microdialysis and the 5-HT 1A receptor antagonist 4-(2′-methoxy-)-phenyl-1-[2′-( N-2″-pyridinyl)- p-fluorobenzamido-]ethyl-piperazine ( p-MPPF). Pretreatment with p-MPPF significantly augmented the increase in extracellular levels of both 5-HT and dopamine in the nucleus accumbens produced by systemic administration of cocaine. Levels of 5-HT or dopamine were unaffected by p-MPPF given alone. Extracellular levels of 5-HT and dopamine were increased dramatically by cocaine infused locally into the nucleus accumbens. Systemic injection of cocaine given during the cocaine infusion reduced 5-HT and dopamine levels, presumably by activating inhibitory 5-HT and dopamine autoreceptors outside of the locus of infusion. The reduction of 5-HT and dopamine levels by systemic cocaine during accumbal infusion was blocked by pretreatment with the 5-HT 1A receptor antagonist p-MPPF. Taken together, these findings suggest that the 5-HT 1A autoreceptor acts to modulate the effects of cocaine on both 5-HT and dopamine levels in the nucleus accumbens.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
